[Ovid] GLP-1 receptor agonist每SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes

mrgo Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-02 12:01
Reward10points

journalㄩHepatology

AuthorsㄩXianhua Mao; Hong Fan; Man-Fung Yuen; Ramsey Cheung; Wai-Kay Seto; Mindie H. Nguyen

Published dateㄩ--

DOIㄩ10.1097/hep.0000000000001771

PDF linkㄩhttps://journals.lww.com/10.1097/HEP.0000000000001771

Article linkㄩhttps://doi.org/10.1097/hep.0000000000001771

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
otakumaster Post time 25 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list